WAS

WAS

Target · Actin regulator

WAS WASP actin nucleation promoting factor · Wiskott-Aldrich syndrome protein

WAS (WASP actin nucleation promoting factor, also known as WASP, WASPA, IMD2 and THC) is an effector protein for Rho-type GTPases that regulates actin filament reorganisation through the Arp2/3 complex. Mutations in the WAS gene cause Wiskott-Aldrich syndrome. Browse Assay Genie's current range of WAS research reagents below, or read on for the biology behind the target.

Cytoskeleton and nucleusArp2/3 effector proteinHaematopoietic-cell expression
502 aa
Protein length
~53 kDa
Molecular weight
Xp11.23
Gene locus
WASP family
Protein family
Target information

What is WAS (WASP actin nucleation promoting factor)?

WAS acts as an effector for Rho-type GTPases and regulates actin filament reorganisation through its interaction with the Arp2/3 complex, which makes it important for efficient actin polymerisation. UniProt describes it as a possible regulator of lymphocyte and platelet function. It also mediates actin filament reorganisation and the formation of actin pedestals when cells are infected by pathogenic bacteria.

Beyond its role in the cytoplasmic cytoskeleton, WAS promotes actin polymerisation in the nucleus, where it influences gene transcription and the repair of damaged DNA. By driving nuclear actin polymerisation, it promotes homologous recombination repair after DNA damage and contributes to the motility of double-strand breaks. The protein is annotated to the cytoplasm and cytoskeleton as well as the nucleus.

The WAS protein belongs to the Wiskott-Aldrich Syndrome protein family, whose members share a similar domain structure and transduce signals from cell-surface receptors to the actin cytoskeleton. The range of motifs in these proteins suggests regulation by many different stimuli and interaction with multiple partners. Studies have shown that family members associate, directly or indirectly, with the small GTPase Cdc42 and with the Arp2/3 cytoskeletal organising complex.

The WAS gene product is a cytoplasmic protein expressed exclusively in haematopoietic cells. Mutations in the WAS gene cause Wiskott-Aldrich syndrome, a rare, inherited, X-linked recessive disease characterised by immune dysregulation and microthrombocytopenia; haematopoietic cells from affected patients show signalling and cytoskeletal abnormalities. This history explains the earlier gene names, including thrombocytopenia 1 (X-linked) and Wiskott-Aldrich syndrome (eczema-thrombocytopenia). A transcript variant arising from alternative promoter usage has also been described, although its full-length nature is not known.

Actin cytoskeleton dynamics

WAS links Rho-type GTPase signals to the Arp2/3 complex, making it a central protein for studying how actin polymerisation is regulated.

Immunology and haematology

WAS is expressed exclusively in haematopoietic cells and is a possible regulator of lymphocyte and platelet function.

Wiskott-Aldrich syndrome research

Mutations in the WAS gene cause an X-linked recessive disease marked by immune dysregulation and microthrombocytopenia.

DNA repair and nuclear actin

Nuclear WAS promotes actin polymerisation, regulating transcription and supporting homologous recombination repair of double-strand breaks.

Background

WAS frequently asked questions

What does WAS do?

WAS is an effector for Rho-type GTPases that regulates actin filament reorganisation through the Arp2/3 complex and is important for efficient actin polymerisation. It also acts in the nucleus, where nuclear actin polymerisation regulates transcription and promotes homologous recombination repair of DNA double-strand breaks.

What other names are used for WAS?

The gene is also called WASP, WASPA, IMD2 and THC, and the full name is WASP actin nucleation promoting factor. Earlier names include thrombocytopenia 1 (X-linked) and Wiskott-Aldrich syndrome. UniProt lists the protein as actin nucleation-promoting factor WAS. A transcript variant from alternative promoter usage has been described.

How is WAS linked to disease?

Mutations in the WAS gene cause Wiskott-Aldrich syndrome, a rare, inherited, X-linked recessive disorder characterised by immune dysregulation and microthrombocytopenia. Haematopoietic cells from affected patients show signalling and cytoskeletal abnormalities, consistent with the protein's role in linking cell-surface signals to actin.

Explore

Related targets

Other Wiskott-Aldrich Syndrome protein family members and actin-regulatory partners with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P42768; product specifications from Assay Genie datasheets.

WAS Product listing